New Breastlight Data Confirms Accuracy in Detecting Malignant Tumours

By Pwb Health Ltd, PRNE
Wednesday, June 16, 2010

In a Trial of 300 Women Breastlight Detected Malignancies as Small as 7mm

LONDON, June 17, 2010 - Data presented today at the European Institute of Oncology's
12th Milan Breast Cancer Conference confirms that Breastlight detects
malignant tumours, picking up lesions as small as 7mm.(1)

The hand held device, for women to use at home, was trialled
at a breast clinic in Sunderland City Hospital involving 300 women. Patients
were examined with Breastlight and findings compared to mammography,
ultrasound and biopsy.


    - detected 12 out of 18 confirmed malignant tumours(1)
      (sensitivity of 67%)
    - correctly identified as negative 240 out of 282 breasts(1)
      (specificity of 85%)
    - detected malignant tumours as small as 7mm(1) (malignancies below
      1.8cm are considered non-palpable(2))

"We were impressed with the sensitivity and specificity of the
Breastlight device. Mammography sensitivity falls between 60% and 90% and
specificity falls between 75% and 95%. Breastlight's sensitivity was 67% with
specificity at 85%. We are not saying that Breastlight could replace
mammography but it can reliably pick up abnormal lumps which can be
investigated to assess whether benign or malignant," said Mr Matei Dordea,
specialist registrar at Sunderland City Hospital.

The Sunderland team see Breastlight's role in women who find
palpation difficult: "Women who have confirmed recurrent cysts find it
difficult to palpate. As benign cysts tend not to have a blood supply, they
will not show up with Breastlight. However, if women feel new cysts they
should always seek medical advice."

This Morning's Dr Chris Steele said: "This latest evidence
confirms Breastlight's place alongside traditional methods of breast
awareness at home. When used in conjunction with self examination, it could
help women detect abnormalities early. It reminds women to get into a good
routine and has been clinically proven to detect malignant disease that
cannot be felt by hand."

Breastlight has been evaluated at-home in a User Study involving over
1,200 women.(3) Results showed that Breastlight encourages breast
examination, at recommended frequency levels, and it gives women confidence
in their breast examination:

    - 80% of women said they felt more confident when using
      Breastlight in addition to their existing routine(3)
    - pre-Breastlight, 34% of women checked their breasts less than
      once every three months. Post-Breastlight this was reduced to 10%(3)
    - once a month checkers, increased from 44% pre-Breastlight to 76%
    - all women in the study continued with their usual practice
      including self examination and attending mammograms(3)

Breastlight is a UK invention that works by shining a very bright but
harmless red LED light through breast tissue. Veins and other blood vessels
show up as dark lines, often referred to as the 'map' of the breast. This is

If a woman detects dark spots or shadows, this is generally an indication
that there is an abnormality. This could be the stimulation of blood vessels
(angiogenesis) when a tumour is developing or a benign lesion such as a
bruise or blood filled cyst.

Mr Matei Dordea presents this study on June 17th at the EIO 12th Milan
Breast Cancer Conference.


1. Iwuchukwu O, Keaney N, Dordea M: Analysis of Breastlight findings in
patients with biopsies. City Hospital Sunderland. Presentation given at the
European Institute of Oncology's 12th Milan Breast Cancer Conference

2. Canadian Cancer Society

3. User Study available at

Breastlight is available in Boots GBP84.99 and online at and

Note to Editors:

A picture accompanying this release is available through the PA
Photowire. It can be downloaded from or
viewed at or

For abstract, pictures, case studies, interviews contact Kate Freeman at Breastlight Tel: +44(0)7748-142113. Email: kate at

will not be displayed